Huangqi decoction attenuates CCl<sub>4</sub>-induced liver fibrosis in mice through up-regulation of liver BAMBI expression

Wei JIANG; Ying XU; Xiaoning WANG; Yongping MU; Jiamei CHEN; Wei LIU; Hua ZHANG; Gaofeng CHEN; Jianmei CAO; Ping LIU; Shili JIANG

doi:10.16305/j.1007-1334.2021.2010021

您当前的位置：

首页 >

文章列表页 >

Huangqi decoction attenuates CCl₄-induced liver fibrosis in mice through up-regulation of liver BAMBI expression

更新时间：2022-08-03

- Huangqi decoction attenuates CCl₄-induced liver fibrosis in mice through up-regulation of liver BAMBI expression
- Shanghai Journal of Traditional Chinese Medicine Vol. 55, Issue 3, Pages: 74-80(2021)
- 作者机构：
  
  1.上海中医药大学附属曙光医院，肝病研究所，肝肾疾病病证教育部重点实验室，上海市重点实验室（上海　201203）
  2.上海中医药大学交叉科学研究院（上海　201203）
  3.上海中医药大学研究生院（上海　201203）
- 作者简介：
- 基金信息：
- DOI：10.16305/j.1007-1334.2021.2010021
  CLC：
扫描看全文
Wei JIANG, Ying XU, Xiaoning WANG, et al. Huangqi decoction attenuates CCl₄-induced liver fibrosis in mice through up-regulation of liver BAMBI expression. [J]. Shanghai Journal of Traditional Chinese Medicine 55(3):74-80(2021)
DOI：

Wei JIANG, Ying XU, Xiaoning WANG, et al. Huangqi decoction attenuates CCl₄-induced liver fibrosis in mice through up-regulation of liver BAMBI expression. [J]. Shanghai Journal of Traditional Chinese Medicine 55(3):74-80(2021) DOI： 10.16305/j.1007-1334.2021.2010021.

摘要

目的,2,探讨黄芪汤（HQD）对肝纤维化模型小鼠骨形成蛋白和激活素跨膜抑制剂（BAMBI）的作用。,方法,2,以10% CCl,4,橄榄油溶液2 g/kg腹腔注射建立C57BL/6小鼠肝纤维化模型；于第4周起将造模组小鼠随机分为模型组（M）和黄芪汤组（HQD），每组12只，干预3周；检测各组小鼠的肝功能、肝组织BAMBI及相关胶原基因表达。体外培养LX-2细胞，观察HQD有效组分黄芪总皂苷（AS）和甘草酸（GA）对转化生长因子-β（TGF-β）信号传导和基因表达的影响。,结果,2,与模型组比较，HQD组血清丙氨酸氨基转移酶、门冬氨酸氨基转移酶活性显著降低（,P,<,0.01）；肝组织炎症坏死、胶原沉积均显著减轻（,P,<,0.01）；肝组织I型胶原（Col1a1）和基质金属蛋白酶-12 mRNA水平显著降低（,P,<,0.05），而,Bambi, mRNA表达显著增加（,P,<,0.01）。体外实验结果表明，AS和GA可显著抑制TGF-β1诱导的LX-2细胞活化和胶原合成；显著降低脂多糖诱导LX-2细胞的肿瘤坏死因子-α表达（,P,<,0.01），且显著增加LX-2细胞BAMBI表达（,P,<,0.01）。,结论,2,黄芪汤抗肝纤维化的作用机制可能与抑制肝脏炎症反应及上调BAMBI表达有关。

Abstract

Objective,2,To explore whether BMP and activin membrane bound inhibitor(BAMBI), an endogenous "pseudo-receptor" of transforming growth factor β(TGF-β), could be involved in the anti-liver fibrotic effects of Huangqi decoction(HQD).,Methods,2,Liver fibrosis was induced in male C57BL/6 mice by 10% CCl,4,(2 g/kg body weight,ip,), three times per week, for 6 weeks. From the 4th week, the CCl,4, model mice were randomly divided into two groups: treated with vehicle(M)and HQD, respectively, for 3 weeks through gavage. ,In vitro, cultured LX-2 cells(a human hepatic stellate cell line)were used to detect the effect of HQD’s major effective components astragalosides(AS)and glycyrrhizic acid(GA)on TGF-β signaling and gene expression.,Results,2,HQD treatment significantly attenuated CCl,4,-induced abnormal increase of serum ALT and AST(,P,<,0.01). H,&,E staining and Sirius red staining on liver tissue sections revealed that HQD treatment significantly attenuated CCl,4,-induced liver tissue damage and inflammation, and reduced liver collagen deposition. Real-time PCR results revealed that HQD treatment reduced the abnormal overexpression of collagen-1(,Col,1α1) and matrix metalloproteinase-12(,Mmp,-12)mRNA(,P,<,0.05). Furthermore, compared with the M group, the liver expression of ,Bambi, mRNA was significantly enhanced in the HQD group(,P,<,0.01). Cell culture studies demonstrated that the treatment of LX-2 cells with AS and GA inhibited TGF-β1-induced LX-2 cell activation and collagen synthesis, inhibited lipopolysaccharide-induced tumor necrosis factor-α expression(,P,<,0.01), and enhanced BAMBI expression(,P,<,0.01).,Conclusion,2,These results revealed that inhibiting liver inflammation and upregulating the expression of BAMBI could be one of the important mechanisms for HQD to effectively reduce liver fibrosis.

关键词

黄芪汤黄芪总皂苷甘草酸肝纤维化小鼠骨形成蛋白和激活素跨膜抑制剂TGF-β1

Keywords

Huangqi decoctiontotal astragalus saponinsglycyrrhizic acidliver fibrosisbone morphogenetic protein and activin transmembrane inhibitor (BAMBI)TGF-β1

references

BATALLER R, BRENNER D A. Liver fibrosis[J]. J Clin Invest, 2005, 115(2): 209-218.

SEKI E, SCHWABE R F. Hepatic inflammation and fibrosis: functional links and key pathways[J]. Hepatology, 2015, 61(3): 1066-1079.

慕永平，刘成海，张华. 肝硬化“虚损生积”论——刘平教授学术思想浅析[J]. 上海中医药大学学报,2013, 27(2): 1-4.

刘畅，刘平，慕永平，等. 黄芪汤治疗慢性肝病研究进展[J]. 世界中医药,2015, 10(2): 157-161.

刘平. “病-证-效”结合研究的思考与探索[J]. 上海中医药大学学报,2007, 21(1): 4-7.

龙爱华，刘平，李风华，等. 不同配比黄芪汤干预大鼠胆汁淤积性肝硬化作用观察[J]. 中国实验方剂学杂志,2006, 12(7): 28-30.

仝欣，王高强，王磊，等. 基于肝组织差异蛋白质组解析黄芪汤治疗二甲基亚硝胺大鼠肝纤维化的效应机制[J]. 中国实验方剂学杂志,2010, 16(11): 111-116.

闫晓风，刘平，孙明瑜，等. 黄芪汤对二甲基亚硝胺诱导大鼠肝纤维化模型作用机制研究[J]. 世界华人消化杂志,2010, 18(23): 2410-2415.

王磊，刘平，慕永平，等. 清热利湿与益气古典方剂逆转二甲基亚硝胺大鼠肝硬化的细胞生物学基础研究[J]. 自然科学进展,2007, 17(8): 1026-1035.

时代音，胡春婷，何娅. 黄芪汤对酒精性肝纤维化大鼠TNF-α及TGF-β1的影响[J]. 陕西中医,2011, 32(6): 758-759.

仝欣，陈高峰，陆雁，等. 基于均匀设计分析黄芪汤活性组分抗二甲基亚硝胺大鼠肝纤维化的配伍作用[J]. 中国中西医结合杂志,2011, 31(10): 1389-1393.

邱冰峰，都金星，申定珠，等. 肝细胞向胆管上皮细胞转分化在继发性胆汁淤积性大鼠肝纤维化形成中的作用及黄芪汤组分的干预效应[J]. 中国中西医结合杂志,2010, 30(5): 513-518.

SEKI E, DE MINICIS S, OSTERREICHER C H, et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis[J]. Nat Med, 2007, 13(11): 1324-1332.

LIU C, CHEN X R, YANG L, et al. Transcriptional repression of the transforming growth factor β (TGF-β) Pseudoreceptor BMP and activin membrane-bound inhibitor (BAMBI) by Nuclear Factor κB(NF-κB) p50 enhances TGF-β signaling in hepatic stellate cells[J]. J Biol Chem, 2014, 289(10): 7082-7091.

ONICHTCHOUK D, CHEN Y G, DOSCH R, et al. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI[J]. Nature, 1999, 401(6752): 480-485.

ZHOU Y P, TONG X, REN S, et al. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation[J]. J Ethnopharmacol, 2016(190): 83-90.

ZHANG X, XU Y, CHEN J M, et al. Huang qi decoction prevents BDL-induced liver fibrosis through inhibition of notch signaling activation[J]. Am J Chin Med, 2017, 45(1): 85-104.

IANG S L, HU X D, LIU P. Immunomodulation and liver protection of Yinchenhao decoction against concanavalin A-induced chronic liver injury in mice[J]. J Integr Med, 2015, 13(4): 262-268.

DUARTE S, BABER J, FUJII T, et al. Matrix metalloproteinases in liver injury, repair and fibrosis[J]. Matrix Biol, 2015(44-46): 147-156.

仝欣. 黄芪主要活性成分的药理作用[J]. 时珍国医国药, 2011, 22(5): 1246-1249.

MU Y P, ZHANG X, LI X W, et al. Astragaloside prevents BDL-induced liver fibrosis through inhibition of notch signaling activation[J]. J Ethnopharmacol, 2015(169): 200-209.

LI J Y, CAO H Y, LIU P, et al. Glycyrrhizic acid in the treatment of liver diseases: literature review[J/OL].Biomed Res Int, 2014[2020-10-23]. https://pubmed.ncbi.nlm.nih.gov/24963489/https://pubmed.ncbi.nlm.nih.gov/24963489/.

Views

344

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Mechanism of Huangqi Decoction against liver fibrosis by network pharmacological analysis combined with related cell experiment

Chemical profiling of Huangqi Decoction granules and characterization of absorbed components and metabolites in mice plasma following oral administration based on UHPLC⁃Q⁃Exactive Orbitrap HRMS

A review and commentary on practice and progress of the liver fibrosis treatment with traditional Chinese medicine

Effect of Chaihu Shugan Powder on Notch pathway inhibition of liver fibrosis in rats with chronic steatohepatitis

Research progress on Huangqi Decoction and its single herbs

Related Author

No data

Related Institution

School of Traditional Chinese Medicine， Shanghai University of Traditional Chinese Medicine

Institute of Interdisciplinary Integrative Medicine Research， Shanghai University of Traditional Chinese Medicine

Department of Pediatric， Baoshan Branch， Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

SATCM Third Grade Laboratory of Traditional Chinese Medicine Preparations， Department of Pharmacy， Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Institute of Liver Diseases， Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine（TCM），MOE Key Laboratory of Liver and Kidney Diseases， Shanghai Key Laboratory of Traditional Chinese Clinical Medicine

⁰

Huangqi decoction attenuates CCl4-induced liver fibrosis in mice through up-regulation of liver BAMBI expression

DOI：10.16305/j.1007-1334.2021.2010021

摘要

Abstract

关键词

Keywords

references

Huangqi decoction attenuates CCl₄-induced liver fibrosis in mice through up-regulation of liver BAMBI expression